5 PHARMACEUTICAL PREPARATIONS FOR INDUCING APOPTOSIS, ALSO KNOWN AS PROGRAMMED CELL DEATH, AND PHARMACEUTICAL PREPARATIONS WHICH INTERFERE WITH THE PROCESS OF APOPTOSIS IN ABERRANT CELLS, ALL FOR USE IN THE TREATMENT OF DISEASES LIMITED TO CANCER, RHEUMATOID ARTHRITIS AND DIABETES; DIAGNOSTIC PREPARATIONS FOR CLINICAL MEDICAL USE